Insulin Expression in Livers of Diabetic Mice Mediated by Hydrodynamics-based Administration

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2004 Feb 18

PMID 14966918

Citations 16

Authors

Chen-Xia He

Ding Shi

Wen-Jun Wu

You-Fa Ding

Deng-Min Feng

Bin Lu

Hao-Ming Chen

Ji-Hua Yao

Qi Shen

Da-Ru Lu

Jing-Lun Xue

Affiliations

Soon will be listed here.

Abstract

Aim: Transfer and expression of insulin gene in vivo are an alternative strategy to improve glycemic control in type 1 diabetes. Hydrodynamics-based procedure has been proved to be very efficient to transfer naked DNA to mouse livers. The basal hepatic insulin production mediated by this rapid tail vein injection was studied to determine its effect on the resumption of glycemic control in type 1 diabetic mice.

Methods: Engineered insulin cDNA was inserted into plasmid vectors under a CMV promoter, and transferred into STZ induced diabetic mice by hydrodynamic procedure. Glucose levels, body weight of treated mice, insulin levels, immunohistology of the liver, and quantity of insulin mRNA in the liver were assayed to identify the improvement of hyperglycemic complication after plasmid administration. Sleeping Beauty, a transposon system, was also used to prolong the insulin expression in the liver.

Results: After plasmid administration, Plasma insulin was significantly increased in the diabetic mice and the livers were insulin-positive by immunostaining. At the same time the hyperglycemic complication was improved. The blood glucose levels of mice were reduced to normal. Glucose tolerance of the treated diabetic mice was improved. Body weight loss was also ameliorated. The rapid tail vein injection did not cause any fatal result.

Conclusion: Our results suggested that insulin gene could be efficiently transferred into the livers of diabetic mice via rapid tail vein injection and it resulted in high level of insulin expression. The basal hepatic insulin production mediated by hydrodynamics-based administration improved the glycemic control in type 1 diabetes dramatically and ameliorated diabetic syndromes. Hydrodynamics-based administration offers a simple and efficient way in the study of gene therapy for type 1 diabetes.

Citing Articles

gene transfer suppresses hepatocarcinogenesis by promoting the degradation of Myc and Hras.

Kamioka H, Yogosawa S, Oikawa T, Aizawa D, Ueda K, Saeki C JHEP Rep. 2023; 5(7):100759.

PMID: 37333975 PMC: 10275997. DOI: 10.1016/j.jhepr.2023.100759.

Complement factor B knockdown by short hairpin RNA inhibits laser-induced choroidal neovascularization in rats.

Wang X, Shang Q, Ma J, Liu S, Wang C, Ma C Int J Ophthalmol. 2020; 13(3):382-389.

PMID: 32309173 PMC: 7154198. DOI: 10.18240/ijo.2020.03.03.

Translational Advances of Hydrofection by Hydrodynamic Injection.

Sendra L, Herrero M, Alino S Genes (Basel). 2018; 9(3).

PMID: 29494564 PMC: 5867857. DOI: 10.3390/genes9030136.

Preclinical and clinical advances in transposon-based gene therapy.

Tipanee J, Chai Y, VandenDriessche T, Chuah M Biosci Rep. 2017; 37(6).

PMID: 29089466 PMC: 5715130. DOI: 10.1042/BSR20160614.

Role of recombinant plasmid pEGFP-N1-IGF-1 transfection in alleviating osteoporosis in ovariectomized rats.

Liu H, Zhao H, Chen J, Wu W, Wang H, Jiao G J Mol Histol. 2013; 44(5):535-44.

PMID: 23508541 DOI: 10.1007/s10735-013-9498-3.

References

Muzzin P, Eisensmith R, Copeland K, Woo S . Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats. Mol Endocrinol. 1997; 11(6):833-7. DOI: 10.1210/mend.11.6.0017. View

Kolodka T, Finegold M, Moss L, Woo S . Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proc Natl Acad Sci U S A. 1995; 92(8):3293-7. PMC: 42152. DOI: 10.1073/pnas.92.8.3293. View

Budker V, Zhang G, Knechtle S, Wolff J . Naked DNA delivered intraportally expresses efficiently in hepatocytes. Gene Ther. 1996; 3(7):593-8. View

Ivics Z, Hackett P, Plasterk R, Izsvak Z . Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell. 1997; 91(4):501-10. DOI: 10.1016/s0092-8674(00)80436-5. View

Yin D, Tang J . Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo. FEBS Lett. 2001; 495(1-2):16-20. DOI: 10.1016/s0014-5793(01)02352-3. View

Olivares E, Hollis R, Chalberg T, Meuse L, Kay M, Calos M . Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat Biotechnol. 2002; 20(11):1124-8. DOI: 10.1038/nbt753. View

Yant S, Meuse L, Chiu W, Ivics Z, Izsvak Z, Kay M . Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet. 2000; 25(1):35-41. DOI: 10.1038/75568. View

Jindal R, Karanam M, Shah R . Prevention of diabetes in the NOD mouse by intra-muscular injection of recombinant adeno-associated virus containing the preproinsulin II gene. Int J Exp Diabetes Res. 2002; 2(2):129-38. PMC: 2478535. DOI: 10.1155/edr.2001.129. View

Sugiyama A, Hattori S, Tanaka S, Isoda F, Kleopoulos S, Rosenfeld M . Defective adenoassociated viral-mediated transfection of insulin gene by direct injection into liver parenchyma decreases blood glucose of diabetic mice. Horm Metab Res. 1998; 29(12):599-603. DOI: 10.1055/s-2007-979108. View

10.

Qin L, Ding Y, Pahud D, Chang E, Imperiale M, Bromberg J . Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther. 1997; 8(17):2019-29. DOI: 10.1089/hum.1997.8.17-2019. View

11.

Yang J, Chen S, Huang L, Michalopoulos G, Liu Y . Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology. 2001; 33(4):848-59. PMC: 1821076. DOI: 10.1053/jhep.2001.23438. View

12.

Zhang G, Budker V, Wolff J . High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther. 1999; 10(10):1735-7. DOI: 10.1089/10430349950017734. View

13.

Liu F, Song Y, Liu D . Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999; 6(7):1258-66. DOI: 10.1038/sj.gt.3300947. View

14.

Lee H, Kim S, Kim K, Shin H, Yoon J . Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature. 2000; 408(6811):483-8. DOI: 10.1038/35044106. View

15.

Zhang G, Budker V, Williams P, Subbotin V, Wolff J . Efficient expression of naked dna delivered intraarterially to limb muscles of nonhuman primates. Hum Gene Ther. 2001; 12(4):427-38. DOI: 10.1089/10430340150504046. View

16.

Dong H, Altomonte J, Morral N, Meseck M, Thung S, Woo S . Basal insulin gene expression significantly improves conventional insulin therapy in type 1 diabetic rats. Diabetes. 2002; 51(1):130-8. DOI: 10.2337/diabetes.51.1.130. View

17.

Chang J, Sigal L, Lerro A, Taylor J . Replication of the human hepatitis delta virus genome Is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences. J Virol. 2001; 75(7):3469-73. PMC: 114140. DOI: 10.1128/JVI.75.7.3469-3473.2001. View

18.

Stoll S, Sclimenti C, Baba E, Meuse L, Kay M, Calos M . Epstein-Barr virus/human vector provides high-level, long-term expression of alpha1-antitrypsin in mice. Mol Ther. 2001; 4(2):122-9. DOI: 10.1006/mthe.2001.0429. View

19.

Dong H, Anthony K, Morral N . Challenges for gene therapy of type 1 diabetes. Curr Gene Ther. 2002; 2(4):403-14. DOI: 10.2174/1566523023347689. View

20.

. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes. 1997; 46(2):271-86. View